porphobilinogen has been researched along with iodine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jordan, PM; Shemin, D | 1 |
| Burgess, K; Chung, LY; Kamkaew, A; Kiew, LV; Kue, CS; Lee, HB; Misran, M; Tiew, SX; Voon, SH | 1 |
2 other study(ies) available for porphobilinogen and iodine
| Article | Year |
|---|---|
Purification and properties of uroporphyrinogen I synthetase from Rhodopseudomonas spheroides.
Topics: Ammonia-Lyases; Ammonium Sulfate; Centrifugation, Density Gradient; Chloromercuribenzoates; Chromatography, DEAE-Cellulose; Chromatography, Gel; Drug Stability; Electrophoresis, Disc; Electrophoresis, Polyacrylamide Gel; Ethylmaleimide; Freezing; Glycerol; Hot Temperature; Hydrogen-Ion Concentration; Iodine; Mercaptoethanol; Molecular Weight; Osmolar Concentration; Porphobilinogen; Porphobilinogen Synthase; Rhodobacter sphaeroides; Rhodopseudomonas; Sodium Dodecyl Sulfate; Vibration | 1973 |
Chitosan-Coated Poly(lactic-co-glycolic acid)-Diiodinated boron-Dipyrromethene Nanoparticles Improve Tumor Selectivity and Stealth Properties in Photodynamic Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Boron Compounds; Cell Line, Tumor; Cell Survival; Chitosan; Drug Carriers; Female; Humans; Iodine; Lactic Acid; Mice; Mice, Inbred BALB C; Nanoparticles; Photochemotherapy; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porphobilinogen; Tissue Distribution | 2016 |